Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

TC Chou, P Talalay - Advances in enzyme regulation, 1984 - Elsevier
A generalized method for analyzing the effects of multiple drugs and for determining
summation, synergism and antagonism has been proposed. The derived, generalized …

Drug combination studies and their synergy quantification using the Chou-Talalay method

TC Chou - Cancer research, 2010 - AACR
This brief perspective article focuses on the most common errors and pitfalls, as well as the
do's and don'ts in drug combination studies, in terms of experimental design, data …

Exogenous alanine and/or glucose plus kanamycin kills antibiotic-resistant bacteria

BO Peng, Y Su, H Li, YI Han, C Guo, Y Tian, X Peng - Cell metabolism, 2015 - cell.com
Multidrug-resistant bacteria are an increasingly serious threat to human and animal health.
However, novel drugs that can manage infections by multidrug-resistant bacteria have …

Multi-target therapeutics: when the whole is greater than the sum of the parts

GR Zimmermann, J Lehar, CT Keith - Drug discovery today, 2007 - Elsevier
Drugs designed to act against individual molecular targets cannot usually combat multigenic
diseases such as cancer, or diseases that affect multiple tissues or cell types such as …

Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia

L Wang, GB Zhou, P Liu, JH Song… - Proceedings of the …, 2008 - National Acad Sciences
To enhance therapeutic efficacy and reduce adverse effects, practitioners of traditional
Chinese medicine (TCM) prescribe a combination of plant species/minerals, called …

Analysis of combined drug effects: a new look at a very old problem

TC Chou, P Talalay - Trends in pharmacological sciences, 1983 - cell.com
A simple, general and novel method for the quantitative analysis of combined drug effects is
presented. The procedure determines if the drug combinations are additive, synergistic or …

MuSyC is a consensus framework that unifies multi-drug synergy metrics for combinatorial drug discovery

DJ Wooten, CT Meyer, ALR Lubbock… - Nature …, 2021 - nature.com
Drug combination discovery depends on reliable synergy metrics but no consensus exists
on the correct synergy criterion to characterize combined interactions. The fragmented state …

Systems biology and combination therapy in the quest for clinical efficacy

JB Fitzgerald, B Schoeberl, UB Nielsen… - Nature chemical …, 2006 - nature.com
Combinatorial control of biological processes, in which redundancy and multifunctionality
are the norm, fundamentally limits the therapeutic index that can be achieved by even the …

A three-dimensional model to analyze drug-drug interactions

MN Prichard, C Shipman Jr - Antiviral research, 1990 - Elsevier
Nearly four generations of investigators have studied combined drug effects. Their methods
of generating and analyzing data have changed dramatically over the years but the basic …

Accelerated titration designs for phase I clinical trials in oncology

R Simon, L Rubinstein, SG Arbuck… - Journal of the …, 1997 - academic.oup.com
Background: Many cancer patients in phase I clinical trials are treated at doses of
chemotherapeutic agents that are below the biologically active level, thus reducing their …